| [1] |
El-Batarny AM. Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy [J]. Clin Ophthalmol, 2008, 2(4): 709-716.
|
| [2] |
Farahvash MS, Majidi AR, Roohipoor R, et al. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage [J]. Retina, 2011, 31(7): 1254-1260.
|
| [3] |
杨华, 王保君, 孔德兰. 糖尿病人眼科手术的围术期处理 [J]. 中国实用眼科杂志, 2005, 5(23): 540-541.
|
| [4] |
沈玺, 徐建敏, 李娜, 等. 23G和20G玻璃体手术治疗增生型糖尿病视网膜病变的对比观察 [J]. 中华眼底病杂志, 2012, 28(3): 232-236.
|
| [5] |
李筱荣, 胡博杰, 邵彦. 23G微创玻璃体切割手术治疗糖尿病视网膜病变的临床观察 [J]. 中华眼底病杂志, 2010, 26(2): 173-174.
|
| [6] |
张扬, 戴荣平, 卞爱玲. 玻璃体腔注射雷珠单抗对增殖性糖尿病视网膜病变手术的影响 [J]. 国际眼科杂志, 2015, 15(8): 1450-1454.
|
| [7] |
Jorge R, Costa RA, Calucci D, et al. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study) [J]. Retina, 2006, 26(9): 1006-1013.
|
| [8] |
Ishikawa K, Honda S, Tsukahara Y, et al. Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy [J]. Eye (Lond), 2009, 23(1): 108-111.
|
| [9] |
Arevalo JF, Maia M, Flynn HW, et al. Tractional retinal detachment following intravitreal bevacizumab(Avastin)in patients with severe proliferative diabetic retinopathy [J]. Br J Ophthalmol, 2008, 92(2): 213-216.
|
| [10] |
El-Sabagh HA, Abdelghaffar W, Labib AM, et al. Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications [J]. Ophthalmology, 2011, 118(4): 636-641.
|
| [11] |
Gupta A, Bansal R, Gupta V, et al. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab [J]. Int Ophthalmol, 2012, 32(2): 135-144.
|
| [12] |
Spaide RF, Fisher YL. Intravitreal bevacizumab(Avastin)treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage [J]. Retina, 2006, 26(3): 275-278.
|
| [13] |
Huang YH, Yeh PT, Chen MS, et al. Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage [J]. Retina, 2009, 29(8): 1134-1140.
|
| [14] |
Oshima Y, Shima C, Wakabayashi T, et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment [J]. Ophthalmology, 2009, 116(5): 927-938.,
|
| [15] |
魏雁涛, 蒋欣桐, 张钊填, 等, 玻璃体腔注射雷珠单抗对增生型糖尿病视网膜病变患眼微创玻璃体切割手术及手术后视力的影响 [J]. 中华眼底病杂志, 2015, 31(4): 337-340.
|
| [16] |
刘鹤南, 李迅, 濮伟. 等. 手术前玻璃体腔注射抗血管内皮生长因子单克隆抗体bevacizumab预防增生型糖尿病视网膜病变玻璃体切割手术后玻璃体积血的meta分析 [J]. 中华眼底病志, 2012, 28(3): 281-285.
|
| [17] |
李建军, 张英辉, 王秀超. 康柏西普眼用注射液辅助玻璃体切除术治疗进展型增殖期糖尿病性视网膜病变的临床效果 [J]. 临床和实验医学杂志, 2016, 15(17): 1730-1733.
|